Bibliography
- WOLFF JA, MALONE RW, WILLIAMS P et al.: Direct gene transfer into mouse muscle in vivo. Science (1990) 247:1465–1468.
- TANG DC, DE VIT M, JOHNSTON SA: Genetic immunization is a simple method for eliciting an immune response. Nature (1992) 356:152–154.
- •The first report showing that immunisation with a chimeric DNA preparation resulted in an immune response to the foreign protein encoded in the DNA.
- ULMER JB, DONNELLY JJ, PARKER SE et al.: Heterologous protection against influenza by injection of DNA encoding a viral protein. Science (1993) 259:1745–1749.
- ROBINSON HL, HUNT LA, WEBSTER RG: Protection against a lethal influenza virus challenge by immunization with a hemagglutinin-expressing plasmid DNA. Vaccine (1993) 11:957–960.
- BRAMSON JI, WAN Y-H: The efficacy of genetic vaccination is dependent upon the nature of the vector system and antigen. Expert Opin. Biol. Diet (2002) 2(1):75–85.
- BAROUCH DH, SANTRA S, TENNER-RACZ K et al: Potent CD4+ T cell responses elicited by a bicistronic HIV-1 DNA vaccine expressing gp120 and GM-CSE Immunol (2002) 168:562–568.
- KRIEG AM: CpG motifs in bacterial DNA and their immune effects. Ann. Rev brimunol. (2002) 20:709–760.
- •A comprehensive review outlining the importance of CpG motifs in bacterial DNA.
- ROBINSON HL: New hope for an AIDSvaccine. Nat. Rev Immunol (2002) 2:239–250.
- MODLIN RL: A toll for DNA vaccines. Nature (2000) 408:659–660.
- ••The finding that bacterial DNA with CpGmotifs is recognised by the toll-like receptor 9 (TLR9) on the surface of dendritic cells and thereby facilitates their activation and maturation.
- SATO K, KAWASAKIH, NAGAYAMA H et al: Signalling events following chemokine receptor ligation in human dendritic cells at different developmental stages. mt. Immunol (2001) 13:167–179.
- LANZAVECCHIA A, SALLUSTO F: Regulation of T cell immunity by dendritic cells. Cell (2001) 106:263–266.
- ••Provides a quantitative estimate of the timeneeded to activate naive versus memory T cells following contact with the antigen-presenting cell.
- UWIERA RRE, GERDTS V, PONTAROLLA RA et al.: Plasmid DNA induces increased lymphocyte trafficking: a specific role for CpG motifs. Cell Immunol. (2001) 214:155–164.
- GURUNATHANS, KLINMAN DM, SEDER RA: DNA vaccines: immunology, application and optimization. Ann. Rev Immunol (2000) 18:927–974.
- CHEN Y, WEBSTER RG, WOODLANF DL: Induction of CD8+ T cell responses to dominant and subdominant epitopes and protective immunity to Sendai virus infection by DNA vaccination. Immunol (1998) 160:2425–2432.
- FU TM, FRIEDMAN A, ULMER JB, LIU MA, DONNELLY JJ: Protective cellular immunity: cytotoxic T lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunization. I Virof (1997) 71:2715–2721.
- YOKOYAMA M, ZHANG J, WHITTON JL: DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection. J. Vim/. (1995) 69:2684–2688.
- •A report indicating that bacterial DNA including DNA coding for a foreign protein induces a strong memory response to the foreign proteins.
- THOMSON SA, KHANNA R, GARDNER J et al.: Minimal epitopes expressed in a recombinant polyepitope protein are processed and presented to CD8+ cytotoxic T cells: implications for vaccine design. Proc. Nall Acad. Sci. USA (1995) 63:375–380.
- THOMSON SA, ELLIOTT SL, SHERRITT MA et Recombinant polyepitope vaccines for the delivery of multiple CD8 cytotoxic T cell epitopes. Immunol (1996) 157:822–826.
- HANKE T, SAMUEL RV, BLANCHARD TJ et al.: Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen. J. Vim/. (1999) 73(9):7524–7532.
- RAMSAY AJ, KENT SJ, STRUGNELL RA, SUHRBIER A, THOMSON SA, RAMSHAW IA: Genetic vaccination strategies for enhanced cellular, humoral and mucosal immunity. Immunol. Rev (1999) 171:27–44.
- •A review describing the benefits of a DNA priming and a different booster immunising regime in inducing a much enhanced immune response.
- SLIFKA MK, ANTIA R, WHITMIRE JK, AHMED R: Humoral immunity due to long-lived plasma cells. Immunity (1998) 8:363–372.
- MULLBACHER A: The long-term maintenance of cytotoxic T cell memory does not require persistence of antigen. .1.Exp. Med. (1994) 179:317–321.
- HEDLEY M, CURLEY J, URBAN R: Microspheres containing plasmid-encoded antigen elicits cytotoxic T cell responses. Nat. Med. (1998) 4:365–368.
- O'HAGAN D, SINGH M, UGOZZULI M et al.: Induction of a potent immune response by cationic microparticles with adsorbed human immunodeficiency virus DNA vaccine.' Vim]. (2001) 75:9037–9043.
- ALEXANDER-MILLER MA, LEGGATT GR, BERZOFSKY JA: Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy. Proc. Nati Acad. Sci USA (1996) 93:4102–4107.
- YEE C, SAVAGE PA, LEE PP, DAVIS MM, GREENBERG PD: Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers. Immunol (1999) 162:2227–2234.
- ESTCOURT MJ, RAMSAY AJ, BROOKS A, THOMSON SA, MEDVECKZY CJ, RAMSHAW IA: Prime-boost immunization generates a high frequency, high-avidity CD8+cytotoxic T lymphocyte population. Int. Immunol (2002) 14:31–37.
- RAMSHAW IA, RAMSAY AJ: The prime-boost strategy: exciting prospects for improved vaccination. Immunol Today (2000) 21:163–165.
- LEONG KH, RAMSAY AJ, MORIN MJ et al.: Generation of enhanced immune responses by consecutive immunization with DNA and recombinant fowlpox virus. In: Vaccines 95 Brown F, Chanock R, Ginsberg H, Norrby E (Eds), Cold Springs Harbor Laboratory Press (1995):327–331.
- SCHNEIDER J, GILBERT SC, BLANCHARD TJ et al.: Enhanced immunogenicity for CD8±T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nat. Med. (1998) 4:397–402.
- ALLEN TM, VOGEL TU, FULLER DH et al: Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen. Immunol (2000) 164:4968–4978.
- ••The first detailed report indicating that incontrast to ASCs formed early in an immune response which have a short half-life, those formed later have a very much longer half life. This makes a lot of sense because once affinity maturation of the response has occurred during the first few weeks after infection/vaccination, it is more economical to have long lived ASCs.
- KENT SJ, ZHAO A, BEST SJ, CHANDLER JD, BOYLE DB, RAMSHAW IR: Enhanced T cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus. J. Virol (1998) 72:10180–10188.
- AMARA RR, VILLINGER F, ALTMAN JD et al: Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science (2001) 292:69–74.
- COHEN J: Merck re-emerges with a bold AIDS vaccine. Science (2001) 292:24–25.
- SULLIVAN NJ, SANCHEZ A, ROLLIN PE, YANG Z-Y, NABEL GJ: Development of a preventive vaccine for Ebola virus infection in primates. Nature (2000) 408:605–609.
- BAROUCH DH, SANTRA S, SCHMITZ JA et at: Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. Science (2000) 290:486–492.
- MUSEY L, HUY, ECKERT L, CHRISTENSEN M, KARCHMER T, MCELRATH MJ: HIV-1 induces cytotoxic T lymphocytes in the cervix of infected woman. J. Exp. Med (1997) 185:293–303.
- •An interesting finding showing how infection by HIV following sexual intercourse leads to the localisation of virus-specific cytotoxic T lymphocytes adjacent to the site where infection was initiated, and where further exposure to the virus may occur.
- MILLER CJ, MCGHEER JR, GARDNER MB: Mucosal immunity, HIV transmission and AIDS. Lab. Invest. (1992) 68:129–145.
- RAMSAY AJ: Genetic approaches to the study of cytokine regulation of mucosal immunity. Immunol Cell Biol. (1995) 73:484–488.
- FYAN EF, WEBSTER RG, FULLER DH, HAYNES JR, SAN TORO JC, ROBINSON HL: DNA vaccines: protective immunizations by parental, mucosal, and gene-inoculations. Proc. Nat. Acad. Sci. USA (1993) 90:11278–11482.
- EO SK, GIERYNSKA M, KAMAR AA, ROUSE BT: Prime-boost immunization with DNA vaccine: mucosal route of administration changes the rules. Immunol (2001) 166:5473–5479.
- KLINMAN DM, TAKENO M, ICHINO M et al: DNA vaccines: safety and efficacy issues. Springer Semin. Immunopathol (1997) 19:245–256.
- ADA G, ISAACS D: Carbohydrate: protein conjugate vaccines. Clin. Microbiol Infect. (2002): (in press).
- MOR G, YAMSHCHIKOV G, SEDEGAH M et al.: Induction of neonatal tolerance after administration of a plasmid DNA vaccine. I Clin. Invest. (1996) 98:2700–2705.
- ICHINO M, MOR G, CONOVER J et al: Factors associated with the development of neonatal tolerance after the administration of a plasmid DNA vaccine." Immunol (1999) 162:3814–3818.
- REICHERT JM, PAPUETTE C: Therapeutic cancer vaccines on trial. Nat. Biotech. (2002) 20:659–663.
- ROOK GAW, STANFORD JL: Give us this day our daily germs. ImmunoL Today (1998) 19:113–116.
- ROWE J, MACAUBAS C, MONGER T et al.: Heterogeneity in DTaP vaccine-specific cellular immunity during infancy: relationship to variations in the kinetics of postnatal maturation of systemic Th-1 function. " Infect Dis. (2001)184:80–88.
- RIEDLER J, BRAUN-FAHRLANDER C, EDER M et al: Exposure to farming environment during the first year of life protects against the development of asthma and allergy. Lancet (2001) 358:1129–1133.
- ••A remarkable retrospective study showingthe influence which early exposure to a farming environment has on very young children in greatly reducing the incidence of asthma and other allergies in their later life.
- LAUENER RP, BIRCHLER T, ADAMSKI J et al.: Expression of CD14 and Toll-like receptor 2 in farmers' and non-farmers' children. Lancet (2002) 360:465–466.
- WOHLLEBEN G, ERB K J: Atopic disorders: a vaccine around the corner? Trends Immunol (2001) 22:618–626.
- MCMICHAEL A, HANKE T: The quest for an AIDS vaccine: is the CD8±T cell approach feasible? Nature Immunol. Rey (2002) 2:283–291.
- HO DD, HUANG Y: The HIV-1 vaccine race. Cell (2002) 110:135–138.
Websites
- http://www.asmusa.org/acasrc/aca.l.htm ROBINSON HL, GINSBERG HS, DAVIS HL, JOHNSTON SA, LIU MA: The scientific future of DNA for immunization. A report from The American Academy of Microbiology.
- http://www.fda.gov/cber/gdlns/plasmid.txt Points to consider on plasmid DNA vaccines for preventive infectious disease indications. Food and Drug Administration, Center for Biologics Evaluation and Research, Office of Vaccine Research and Review.
- http://www.iavi.org/trialsdb/IAVI database of preventive AIDS vaccines in human trials, [email protected].